Thaddeus R. Tolleson

A Randomized Comparison of the Endeavor Zotarolimus-Eluting Stent Versus the TAXUS Paclitaxel-Eluting Stent in De Novo Native Coronary Lesions

Martin B. Leon, Laura Mauri, Jeffrey J. Popma et al. · Journal of the American College of Cardiology · 2010 · 240 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Taxus Paclitaxel-eluting Stent +7

Clinical Evaluation of the Resolute Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries

Alan C. Yeung, Martin B. Leon, Ash Jain et al. · Journal of the American College of Cardiology · 2011 · 140 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Native Coronary Arteries +8

Randomized COMparison of Platelet Inhibition With Abciximab, TiRofiban and Eptifibatide During Percutaneous Coronary Intervention in Acute Coronary Syndromes

Wayne Batchelor, Thaddeus R. Tolleson, Yao Huang et al. · Circulation · 2002 · 123 citations · Full text

Relationship between heparin anticoagulation and clinical outcomes in coronary stent intervention

Thaddeus R. Tolleson, J.Conor O’Shea, John A. Bittl et al. · Journal of the American College of Cardiology · 2003 · 106 citations

Thrombosis, Percutaneous Coronary Intervention, Heparin Anticoagulation +12

One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk Patients

David E. Kandzari, Ajay J. Kirtane, Stephan Windecker et al. · Circulation Cardiovascular Interventions · 2020 · 65 citations · Full text